Publications & Academic Activities
Peer-reviewed research, book chapters, abstracts, presentations, invited lectures, and teaching
Peer-Reviewed Publications
2026(3)
Glucagon-like peptide-1 receptor agonists: Considerations for treating preconception obesity
Berube L, Weintraub MA, et al. Obesity. March 2026. [accepted]
Consensus-Based Clinical and Research Recommendations for Glucagon-Like Peptide-1 Receptor Agonist Based Treatments in the Context of Eating Disorders: A Modified Delphi Study
Keshen A, Weintraub MA, et al. World Psychiatry. March 2026. [accepted]
Ranganath M, Chukir T, Desai D, Weintraub MA, Corrigan M, Gianchandani R, Rothberg A. J Clin Endocrinol Metab. March 2026.
2025(2)
Orandi BJ, Chen Y, Li Y, Charyton D, Lentine KL, Lee BP, Ali N, DeMarco MP, Weintraub MA, Bae S, Lonze BE, Ren-Fielding CJ, Lofton H, Gujral A, Segev DL, McAdams-DeMarco M. Clin J Am Soc Nephrol. Jun 17 2025;20(8):1100-1110.
Orandi B, Chen Y, Li Y, Metoyer G, Lentine K, Weintraub MA, Bae Su, Ali N, Lonze B, Ren-Fielding C, Lofton H, Gujral A, Segev D, McAdams-DeMarco M. Lancet Diabetes and Endocrinology. March 2025.
2024(1)
Ayappa I, Laumbach R, Black K, Weintraub MA, Agarwala P, Twumasi A, Sanders H, Udasin I, Harrison D, de la Hoz R, Chen Y, Chitkara N, Mullins A, Castillo HR, Rapoport D, Lu S, Sunderram J. J Clin Sleep Med. 2024 Oct 1;20(10):1627-1636.
2023(2)
Weintraub MA, Liu D, DeMatteo R, Goncalves M, Flory J. Breast Cancer Res Treat. Aug 2023.
Weintraub MA, D'Angelo D, Tchang B, Andre C, Aronne L, Shukla A. J Clin Endocrinol Metab. 2023;108(9):e832-e841.
2022(1)
Characterization, Management, and Risk Factors of Hyperglycemia during PI3K or AKT Inhibitor Treatment
Liu D, Weintraub MA, Garcia C, Goncalves M, Harding JJ, Harnincar S, Casas A, Sisk AE, Drilon A, Jhaveri K, Flory J. Cancer Medicine. Feb 2022.
2021(1)
Weintraub MA, Ameer B, Sinha-Gregory N. J Investig Med High Impact Case Rep. Dec 2021.
2020(1)
Ameer B, Weintraub MA. Obesity. 2020, 28:1013-1022.
2019(3)
Case report of pseudohypoglycemia in a patient with leukocytosis
Weintraub MA, Nandiraju D, Shirodkar MA. The Medicine Forum. 2019, Jun; 20(1): 10.
Metastatic retroperitoneal paraganglioma: Case report and review of the literature
Tabakin AL, Weintraub MA, Radadia KD, Salazar CG, Sadimin E, Singer EA. Clin Oncol (Belmont). 2019;4:1589.
Sunderram J, Weintraub M, Black K, et al. Chest. 2019 Feb;155(2):375-83.
2018(2)
Ameer B, Weintraub MA. Journal of Clinical Pharmacology. 2018, Oct; 58(Suppl 10): S94-S107.
Roth spots in endocarditis case presentation
Weintraub MA. The Medicine Forum. 2018, Jun; 19(1): 9.
2015(1)
Scheving LA, Zhang X, Stevenson MC, Weintraub MA, et al. Am J Physiol Gastrointest Liver Physiol. 2015 Dec 15;309(12):942.
2010(2)
Letter from the Editor
Weintraub MA. Penn Bioethics Journal. 2010, Fall; 6(2):3.
Letter from the Editor
Weintraub MA. Penn Bioethics Journal. 2010, Spring; 6(1):1.
Book Chapters
Ameer B, Weintraub MA. (2024). Handbook of Obesity, (5th ed.) CRC Press.
Pituitary tumors: prolactinomas, Cushing's disease, growth hormone producing tumors
Weintraub MA, Henderson F, Schwartz T, Dobri G. (2024). CURRENT Lange Endocrine Surgery (1st ed.)
Peer-Reviewed Abstracts
Real-world adherence and persistence of GLP-1 based treatments in patients with type 2 diabetes
Girgis MS, Almandoz JP, Weintraub MA, Chang ET, Saleem N, Muntner P, Dluzniewski PJ. American Diabetes Association Scientific Sessions, 2026.
Real-world adherence and persistence of GLP-1 based treatments in patients with type 2 diabetes
Girgis MS, Almandoz JP, Weintraub MA, Chang ET, Saleem N, Muntner P, Dluzniewski PJ. European Association for the Study of Diabetes Conference, 2025.
Preliminary Assessment of GLP-1 receptor agonists on testosterone levels, erectile function, and metabolic outcomes in men with obesity or type 2 diabetes
Eid N, Soriano V, Williams K, Natter M, Weintraub M, Sadeghi-Nejad H. Journal of Urology, 2025 May. 213(5S):e541.
Extent of use of biomarkers alongside clinical outcome assessments in drug investigations for rare diseases
Ameer B, Weintraub M. Division of Medicinal Chemistry, ACS National Meeting, Abstract #3927583, in-person, San Francisco, CA August 2023.
"MP74-1 How do Tiktok users present third line OAB therapies to the public?"
Tabakin AL, Choi S, Sandozi A, Aibel K, Weintraub M, Winkler H, Shalom D, Tam J, Lee W. Journal of Urology, 209(S4); e1076.
A case of Graves' disease after the SARS-CoV-2 vaccine
Weintraub MA, Sinha-Gregory N. Thyroid. Sept 2021. A73-A74.
Challenges in estrogen therapy in male-to-female transition
Weintraub MA, Ameer B, Tabakin AL, Hyland KA. American Association of Clinical Endocrinologists 29th Annual Scientific and Clinical Congress, Abstract # 785283, Washington, DC May, 2020. Endocrine Practice 2020;26:Suppl 2, 178.
A case of familial hypocalciuric hypercalcemia
Weintraub MA, Nandiraju D. American Association of Clinical Endocrinologists 29th Annual Scientific and Clinical Congress, Abstract # 799571, Washington, DC May, 2020. Endocrine Practice 2020;26:Suppl 2, 46.
A case of intranasal fluticasone-induced adrenal insufficiency
Weintraub MA, Lessard K, Kouvatsos T. American Association of Clinical Endocrinologists 29th Annual Scientific and Clinical Congress, Abstract # 781528, Washington, DC May, 2020. Endocrine Practice 2020;26:Suppl 2, 196.
A case of pseudohypoglycemia in a patient with leukocytosis
Weintraub MA, Nandiraju D, Shirodkar M. (April 2019). American Association of Clinical Endocrinologists 28th Annual Scientific and Clinical Congress, Los Angeles, CA. Endocrine Practice 2019;25:Suppl 1.
Knowledge gaps about common drugs in obese pediatric patients
Ameer B, Weintraub M. Clinical Pharmacology in Drug Development. 2018, Sep; 7(S1): 69.
Poster Presentations
"Extent of use of biomarkers alongside clinical outcome assessments in drug investigations for rare diseases"
Ameer B, Weintraub M. (August 2023). Poster presented in-person at the ACS National Meeting, Division of Medicinal Chemistry, San Francisco, CA. Abstract #3927583.
"Effect of concurrent psychotropic medication use on long-term medical weight loss outcomes"
Salas A, Weintraub, MA, Aronne, LJ, Shukla, AP. (November 2022). Poster presented at ObesityWeek 40th Annual Scientific Meeting of the Obesity Society, San Diego, CA.
"Management of alpelisib-induced hyperglycemia"
Weintraub MA, Lu D, Flory J. (June 2022). Poster presented at American Diabetes Association 82nd Scientific Sessions; New Orleans, LA.
"SARS-CoV-2 vaccine associated thyroid abnormalities"
Weintraub MA, Ameer B, Sinha-Gregory N. (September 2021). Poster presented virtually at American Thyroid Association National Meeting.
Increasing awareness for the opioid aftercare coordination service
Weintraub MA, Wang H, Dikdan S, et al. (June 2019). Poster presented at: Quality Improvement and Patient Safety Poster Session of Jefferson University Hospital; Philadelphia, PA.
Knowledge gaps about common drugs in obese pediatric patients
Ameer B, Weintraub MA. (September 2018). Poster presented at: American College of Clinical Pharmacology Annual Meeting; North Bethesda, MD.
Chronic rhinosinusitis Is an independent risk factor for obstructive sleep apnea in World Trade Center responders
Weintraub MA, Sunderram J, Kipen H, et al. (May 2017). Poster presented at: American Thoracic Society National Meeting; Washington, DC.
Possible drug-induced Stevens-Johnson Syndrome vs. Erythema Multiforme in a patient taking oxcarbazepine and quetiapine
Papoosha, M, Wattamwar, K, Weintraub, MA, et al. (June 2016). Poster presented at: Meridian Health Research Day; Neptune, NJ.
Disruption of hepatocellular ERBB3 expression suppresses diethylnitrosamine-induced hepatocellular carcinogenesis
Weintraub MA, Zhang X, Abbasi A, Scheving LA, Russell WE. (April 2015). Poster presented at: American Society for Clinical Investigation and Association of American Physicians National Meeting; Chicago, IL.
Blocking viral vector antigen presentation using TAP inhibitors
Weintraub MA, Finn J, High KA. (April 2011). Poster presented at: Penn Symposium for Undergraduate Research in Biology; Philadelphia, PA.
Oral Presentations
Weight change after GLP-1 discontinuation in US patients living with overweight/obesity or diabetes
Girgis MS, Almandoz JP, Weintraub MA, Chang ET, Saleem N, Muntner P, Dluzniewski PJ. (November 2025). Oral presentation at: Obesity Week; Atlanta, GA.
Long-term weight loss maintenance with obesity pharmacotherapy: A 5-year retrospective study
Weintraub MA, Andre C, D’Angelo D, Tchang B, Aronne L, Shukla A. (June 2022). Oral presentation at: ENDO National Meeting; Atlanta, GA.
A challenging case of Cushing’s disease
Weintraub MA. (March 2022). Oral presentation at: The Pituitary Society’s Pituitary Master Course — Essentials of Pituitary Diseases for Fellows-in-Training.
A case of Graves’ disease after the SARS-CoV-2 vaccine
Weintraub MA. (November 2021). Oral presentation at: New York Thyroid Club Meeting.
A patient with skeletal fluorosis due to inhalant abuse
Weintraub MA, Collins MT, Bates DD, Farooki A. (September 2021). Oral presentation virtually at: American Society for Bone and Mineral Research Annual Meeting Endocrine Fellows Forum.
Case presentation of a TSH-secreting pituitary adenoma
Weintraub MA. (April 2021). Oral presentation at: The Pituitary Society’s Pituitary Master Course — Essentials of Pituitary Diseases for Fellows-in-Training.
Case presentation in symposium “Pharmacogenomic and genetic variation in different geographic regions”
Weintraub MA. (September 2010). Oral presentation at: American College of Clinical Pharmacology Annual Meeting; Baltimore, MD. Panel discussion on genetic testing and implications of genetic variation across populations in the diagnosis of disease.
Invited Presentations
National & International Conferences
Obesity-related cardiovascular and renal disease: Risks and care strategies
Columbia–Cornell Obesity Course. May 2026.
Targeting cardiometabolic inflammation in obesity and type 2 diabetes with GLP-1 based therapies
NYU 6th Annual North American Cardiometabolic Risk in Inflammatory Disease Conference. April 2026.
GLP-1 receptor agonists and sleep medicine
New York Sleep Conference: Cutting Edge Topics in Sleep Medicine. April 2025.
Newer generation anti-obesity medications: Impact on cardiovascular and renal health
Cornell Qatar — Tackling Obesity: Multidisciplinary Approaches for Comprehensive Care. January 2025.
GLP-1 medications: Is there anything they can’t do?
NYU Dietary and Lifestyle Strategies for Cardiovascular Risk Reduction Conference. November 2024.
Updates in the pharmacologic treatment of obesity
NYU Endocrinology Updates CME Conference. March 2024.
Visiting Professorships & External Grand Rounds
Update on the pharmacologic management of obesity
St. John’s Episcopal Hospital, Family Medicine Grand Rounds. August 2025.
Update on the pharmacologic management of obesity
St. John’s Episcopal Hospital, Internal Medicine Grand Rounds. November 2024.
How to successfully manage obesity in the primary care setting
University of Rochester Primary Care Grand Rounds. July 2024.
Pharmacologic treatment strategies of obesity
Maniya Health Primary Care Group Grand Rounds. May 2024.
Institutional & Departmental Lectures
Top 5 questions about weight loss medications: What you need to know
NYU Preventative Cardiology Heart Health Lecture Series. September 2024.
Long-term weight loss maintenance with obesity pharmacotherapy
NYU Langone Endocrinology Grand Rounds. February 2023.
Long-term weight loss maintenance with anti-obesity medications
Weill Cornell, Memorial Sloan Kettering Endocrinology, and Hospital for Special Surgery Joint Grand Rounds. May 2022.
Graves’ disease after the SARS-CoV-2 vaccine
Weill Cornell, Memorial Sloan Kettering Endocrinology, and Hospital for Special Surgery Joint Grand Rounds. June 2021.
Teaching Activities
Undergraduate Medical Education (UME)
Pituitary physiology — annual lecture, 2023–2026
NYU Grossman School of Medicine, Medical Student Endocrinology Lecture Series. Delivered March 2023, February 2024, April 2025, March 2026.
Obesity: Metabolic complications
NYU Grossman School of Medicine, Medical Student Endocrinology Lecture Series. March 2026.
Graduate Medical Education (GME)
Obesity: Diagnosis and management
NYU Endocrinology Fellowship Lecture. April 2026.
Type 2 diabetes management: A weight-centric and cardioprotective approach — annual lecture, 2023–2025
Weill Cornell Obesity Fellowship Lecture Series. Delivered January 2023, March 2024, April 2025.
Curriculum & Module Development
The state of obesity medicine — annual keynote lecture, 2023–2025
Endocrine Society’s Obesity Fellows Program. Delivered October 2023, September 2024, September 2025.
Genetic and environmental pathophysiology of obesity
Endocrine Society’s Obesity Fellows Program Online Curriculum. October 2023.
Evaluation and treatment of endocrine comorbidities of obesity (online learning module)
American Association of Clinical Endocrinology Obesity Learning Modules. 2024.